Harmony BiosciencesvsJohnson & Johnson

HRMY and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

HRMY

Harmony Biosciences Holdings, Inc.

$32.59

Value $1.9B

-1.18%
HRMY's page

Harmony Biosciences (HRMY) has a market value of $1.9B and Johnson & Johnson (JNJ) $651B. Over the last year, with dividends, HRMY moved -2.2% and JNJ +36.3%. The P/E is 10.6 for HRMY and 40.5 for JNJ. Dividend yield: HRMY none, JNJ 1.95%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    HRMY$1.9B

    JNJ$651B

    JNJ is 346 times HRMY

  • Revenue, 12 months

    HRMY$989M

    JNJ$99.3B

    JNJ is 100 times HRMY

  • Net income, 12 months

    HRMY$179M

    JNJ$16.1B

    JNJ is 90 times HRMY

  • Operating margin

    HRMY22.2%

    JNJ–

  • ROIC

    HRMY15.3%

    JNJ12.4%

    2.9 points apart

  • P/E

    HRMY10.6

    JNJ40.5

    JNJ is 3.8 times HRMY

  • Dividend yield

    HRMY0.0%

    JNJ2.0%

    2.0 points apart

  • 5-year return

    HRMY-15.9%

    JNJ+90.5%

    106.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

HRMY-15.9%

JNJ+90.5%

5010015020020222023202420252026
Returns by period
PeriodHRMYWith dividendsJNJWith dividends
1 year since November 19, 2025-2.2%Price -2.2%+36.3%Price +33.3%
3 years since November 20, 2023+17.4%+5.5% a yearPrice +17.4%+94.5%+24.8% a yearPrice +80.1%
5 years since November 19, 2021-15.9%-3.4% a yearPrice -15.9%+90.5%+13.8% a yearPrice +65.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

HRMYHarmony BiosciencesJNJJohnson & Johnson

Valuation

HRMYJNJ
Valuation
Price$32.59$270.30
Market value$1.9B$651B
Enterprise value (EV)$1.3B$679B
P/E10.640.5
P/E, 5-year median15.221.9
P/B1.88.0
EV/EBIT5.838.3
Free cash flow yield17.1%3.2%

Results and growth

HRMYJNJ
Results and growth
Revenue, 12 months$989M$99.3B
Net income, 12 months$179M$16.1B
Free cash flow, 12 months$323M$20.6B
Earnings per share, 12 months$3.03$6.59
Revenue growth, year on year21.5%6.1%
Revenue growth a year, past+40.3%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

HRMYJNJ
Margins and returns on capital
Gross margin74.0%67.6%
Operating margin22.2%–
Net margin18.1%16.2%
ROIC15.3%12.4%
ROE19.1%19.7%

Balance sheet

HRMYJNJ
Balance sheet
Cash$771M$17.2B
Total debt$155M$44.7B
Net debt / EBITDA–1.1
Interest cover17.0×18.0×

Dividends and buybacks

HRMYJNJ
Dividends and buybacks
Dividend yield–2.0%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield–0.9%
Shareholder yield–2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: HRMY or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Harmony Biosciences or Johnson & Johnson?

By market value, Johnson & Johnson ($651B) is about 345.6 times Harmony Biosciences ($1.9B), at today's prices.

How did HRMY and JNJ stock do over the last 5 years?

Since November 19, 2021, HRMY's price moved -15.9% and JNJ's +65.7%. With dividends: HRMY -15.9% (-3.4% a year), JNJ +90.5% (+13.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, HRMY or JNJ?

The dividend yield at today's price is none for Harmony Biosciences and 1.95% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

What is the P/E of HRMY and JNJ?

At today's price, the P/E is 10.6 for HRMY and 40.5 for JNJ. The median of the last five years was 15.2 and 21.9, which shows where each stands against its own past.

Which has the higher profit margins, Harmony Biosciences or Johnson & Johnson?

Over the last twelve months, the net margin was 18.1% for Harmony Biosciences and 16.2% for Johnson & Johnson, and the operating margin 22.2% and –. Revenue was $989M and $99.3B.

Which is the better investment, Harmony Biosciences or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.